National kidney foundation honors caredx with corporate citizenship award for its commitment to the transplant community

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the national kidney foundation honored caredx with a corporate citizenship award during its 41st annual kidney ball held on march 31, 2023, in washington, d.c.
CDNA Ratings Summary
CDNA Quant Ranking